Literature DB >> 16882448

Clinical inquiries. How should we manage a patient with a positive PPD and prior BCG vaccination?

Kathleen Rowland1, Richard Guthmann, Barbara Jamieson, Drew Malloy.   

Abstract

Prior bacille Calmette-Guerin (BCG) vaccination increases the likelihood of a positive tuberculosis (TB) 5TU purified protein derivative (PPD) skin test. The PPD response following BCG vaccine varies with age at vaccination, number of years since the BCG vaccination, number of times vaccinated, and number of PPDs performed. An induration of greater than 14 mm is unlikely to be due to prior BCG vaccination (strength of recommendation [SOR]: A, based on meta-analysis of validation cohort studies). The variable reaction after BCG vaccination, along with the desire to detect all cases of TB, has led to recommendations that all patients with a positive PPD test be treated as true positives. These patients should undergo chest radiography and appropriate treatment, regardless of history of BCG vaccine (SOR: B, extrapolation from level 1 study). A recently developed alternative is the interferon-gamma assay (QuantiFERON-TB Gold test), which may be used in place of, or in addition to, the PPD skin test for patients who are known to have received a BCG vaccine (SOR: B, extrapolation from a validation cohort study).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882448

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  10 in total

1.  Anti-tuberculous therapy combined with systemic corticosteroids improves retinal sensitivity in patients with active presumed tuberculous choroiditis.

Authors:  Ahmed M Abu El-Asrar; Hani S Al-Mezaine
Journal:  Int Ophthalmol       Date:  2010-05-15       Impact factor: 2.031

2.  Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results?

Authors:  Roi Piñeiro; María José Mellado; María José Cilleruelo; Marta García-Ascaso; Antonio Medina-Claros; Milagros García-Hortelano
Journal:  Eur J Pediatr       Date:  2012-07-01       Impact factor: 3.183

3.  Tuberculous uveitis.

Authors:  Ahmed M; Abu El-Asrar; Marwan Abouammoh; Hani S Al-Mezaine
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

4.  Tubercular Uveitis with Ocular Manifestation as the First Presentation of Tuberculosis: A Case Series.

Authors:  Jayashree S Shah; Niharika Shetty; Sharath Kumar D Shah; Neelesh Kumar S Shah
Journal:  J Clin Diagn Res       Date:  2016-03-01

5.  Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis.

Authors:  Hani S Al-Mezaine; Abdulrahman Al-Muammar; Dustan Kangave; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2007-11-22       Impact factor: 2.031

6.  Pattern of uveitis at a referral center in Iraq.

Authors:  Faiz I Al-Shakarchi
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Oct-Dec

7.  Occupational health risks of pathologists--results from a nationwide online questionnaire in Switzerland.

Authors:  Florian Rudolf Fritzsche; Constanze Ramach; Davide Soldini; Rosmarie Caduff; Marianne Tinguely; Estelle Cassoly; Holger Moch; Antony Stewart
Journal:  BMC Public Health       Date:  2012-12-06       Impact factor: 3.295

Review 8.  Ocular tuberculosis: current perspectives.

Authors:  Faiz I Shakarchi
Journal:  Clin Ophthalmol       Date:  2015-11-26

9.  Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).

Authors:  Margret Johansson Gudjónsdóttir; Karsten Kötz; Ruth Stangebye Nielsen; Philip Wilmar; Sofia Olausson; Daniel Wallmyr; Birger Trollfors
Journal:  BMC Infect Dis       Date:  2016-10-06       Impact factor: 3.090

10.  Comparison of tuberculin skin test and QuantiFERON-TB Gold In-Tube test in Bacillus Calmette-Guerin-vaccinated children.

Authors:  Ira Shah; Jagdish Kathwate; Naman S Shetty
Journal:  Lung India       Date:  2020 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.